Please login to the form below

Not currently logged in
Email:
Password:

myeloma

This page shows the latest myeloma news and features for those working in and with pharma, biotech and healthcare.

FDA hands BMS and bluebird bio a priority review for ide-cel

FDA hands BMS and bluebird bio a priority review for ide-cel

The immunotherapy, idecabtagene vicleucel (ide-cel/bb2121), is designed to treat adult patients with relapsed and refractory myeloma. ... BMS and bluebird bio are aiming for approval of ide-cel in adult patients with multiple myeloma who have received

Latest news

More from news
Approximately 83 fully matching, plus 245 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
...
Can eLearning improve patient recruitment and retention?
Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....
How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...

Infographics